Correlation Between Gilead Sciences and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and ANI Pharmaceuticals, you can compare the effects of market volatilities on Gilead Sciences and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and ANI Pharmaceuticals.
Diversification Opportunities for Gilead Sciences and ANI Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gilead and ANI is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Gilead Sciences and ANI Pharmaceuticals
Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.7 times more return on investment than ANI Pharmaceuticals. However, Gilead Sciences is 1.42 times less risky than ANI Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest 7,153 in Gilead Sciences on August 24, 2024 and sell it today you would earn a total of 1,863 from holding Gilead Sciences or generate 26.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. ANI Pharmaceuticals
Performance |
| Timeline |
| Gilead Sciences |
| ANI Pharmaceuticals |
Gilead Sciences and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and ANI Pharmaceuticals
The main advantage of trading using opposite Gilead Sciences and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.| Gilead Sciences vs. Merck Company | Gilead Sciences vs. Pfizer Inc | Gilead Sciences vs. Eshallgo Class A | Gilead Sciences vs. Amtech Systems |
| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |